Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | AGXT | P21549 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | LPL | P06858 | 2/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25521962 | 0.86 | TAAR1 (0.45) | RIPK1TAAR1LPLLIPG | |
| SCHEMBL11966955 | 0.82 | RIPK1 (0.49) | RIPK1TAAR1IDO1AGXTMAOB | |
| SCHEMBL11613933 | 0.81 | IDO1 (0.44) | RIPK1TAAR1IDO1AGXTMAOB | |
| SCHEMBL27490625 | 0.79 | SLC6A2 (0.45) | TAAR1 | |
| SCHEMBL2782164 | 0.79 | SLC6A2 (0.45) | TAAR1 | |
| SCHEMBL21227104 | 0.78 | IDO1 (0.46) | RIPK1TAAR1IDO1AGXTGGPS1 | |
| Ammonia Solution, Strong SCHEMBL27433180 | 0.77 | SLC6A2 (0.44) | TAAR1 | |
| Water SCHEMBL28220897 | 0.77 | HTT (0.45) | TAAR1 | |
| Water SCHEMBL28220900 | 0.77 | HTT (0.45) | TAAR1 | |
| Ammonia Solution, Strong SCHEMBL27641275 | 0.77 | SLC6A2 (0.44) | TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210008045-A1 | PANICINOTAM DERIVATIVE, PREPARATION METHOD AND USE THEREOF | OCEAN UNIVERSITY OF CHINA (CN) | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210008045-A1 | PANICINOTAM DERIVATIVE, PREPARATION METHOD AND USE THEREOF | TPMT, PBRM1, PGM2 | RIPK1 1270/4885TAAR1 1519/4885IDO1 305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.